Search
Now showing items 1-10 of 12
Out of range laboratory values: a major reason for exclusion from a phase 1 HIV vaccine clinical trial
(University of Nairobi, 2006)
Safety and immunogenicity of DNA and MVA HIVA vaccines in Phase-1 vaccine trials in Nairobi, Kenya
(University of Nairobi, 2004)
Safety profile of DNA and MVA HIV preventive vaccines
(University of Nairobi, 2004)
Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa
(University of Nairobi, 2009-10)
HIV vaccine clinical trials enrollment and retention: Experience from Kenya AIDS Vaccine Initiative
(University of Nairobi, 2005)